On-Demand Treasury Management System Provides Greater Control Over Bank Account Management
TreasuryXpress, the global leader in frictionless and on-demand treasury management software today announced that major pharmaceutical product distributor, Omnipharma, has selected the firm’s enterprise treasury management solution, C2Treasury™, to help achieve greater control over their bank account management and cash management processes.
For Omnipharma, the ability to achieve greater control over their bank account management was critical to restructuring their cash management processes. C2Treasury provides companies of any size access to enterprise-level cash visibility, liquidity management, bank connectivity, payments workflow, and self-service custom reporting capabilities; thereby streamlining cash management processes.
“As a leader in their industry, we are pleased that Omnipharma has selected C2Treasury to help them assert greater control and efficiency across their treasury operations,” say Anis Rahal, CEO and founder of TreasuryXpress.
Committed to delivering a frictionless user experience, C2Treasury is delivered by client’s choice of deployment – single-tenant SaaS (ASP), direct-to-private cloud, multi-tenant SaaS, or on premise. Omnipharma will be deploying the solution via on-premise installation.
TreasuryXpress, a global FinTech provider, was created with one simple aim - to give all companies powerful, cost-effective, and easy-to-implement Treasury Management capabilities that empower them to be able to work smarter!
At TreasuryXpress, we specialize in delivering innovative solutions that work for treasury - making it easy to achieve 100% bank visibility, consolidate cash information, manage end-to-end payment processing, and distribute useful and critical reports to all internal stakeholders automatically and efficiently.
Our solutions centralize more than 10,000 bank accounts daily and process electronic payments for over 7 billion USD each year. Our rapid time-to-market and diverse hosting options make it easy for treasuries to do business with us. From solution development to delivery and service, our teams actively engage with customers regularly and proactively.
The foundations of Omnipharma were laid down back in 1954, when the families of 'Chaoui' and 'Fadel', represented 'Roche' in Lebanon. In 1975, 'Chaoui' took exclusively the pharmaceutical business of 'Roche', and expanded to become one of the leading providers of health products in Lebanon. The Gebara family led by Joseph Gebara , joined the company at that time. Zafer Chaoui and Joseph Gebara started a partnership which got continiously stronger with time. Their sons, Karim Gebara and Emile Chaoui are presently active on board.
OMNIPHARMA is part of a group of sister companies who represent leading manufacturers, specialized mainly in pharmaceuticals, diagnostics and paper. The companies were established several decades ago and have operations in four countries within the MENA region.